Evonik Industries (ETR:EVK) target price raised to 28.00EUR, reported today by BNP PARIBAS
- Updated: September 16, 2016
In a statement issued on 9/17/2016 BNP PARIBAS raised the target price of Evonik Industries (ETR:EVK) from 0EUR to 28EUR reporting a possible downside of -0.04%.
Previously on 9/16/2016, Citigroup Corp. released a statement on Evonik Industries(ETR:EVK) bumped the target price from 0.00EUR to 38.00EUR that suggested an upside of 0.31%.
Showing a price of 29.09EUR, Evonik Industries (ETR:EVK) traded 4.60% lower on the day. With the last close up 12.06% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. The company has recorded a 50-day moving average of 2.55EUR and two hundred day moving average of 2.03EUR. Trading volume was was up over the average, with 12,913 shares of EVK changing hands over the typical 6,964 shares.
Recent Performance Chart:
With a total market value of 0.0 EUR, Evonik Industries has a 52 week low of 1.35EUR and a 52 week high of 3.28EUR with a PE ratio of 3.
Brief Synopsis On Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company’s activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company’s sites, and among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.